ClinicalTrialsFinder

Refractory Large B-cell Lymphoma Clinical Trials in Seoul, Seoul

1 recruitingSeoul, Seoul, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Relapsed Large B-cell LymphomaRefractory Large B-cell Lymphoma
TICAROS Co., Ltd.98 enrolled1 locationNCT07473167